This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zeitlinger, M. A.
Right arrow Articles by Joukhadar, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zeitlinger, M. A.
Right arrow Articles by Joukhadar, C.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, November 2003, p. 3548-3553, Vol. 47, No. 11
0066-4804/03/$08.00+0     DOI: 10.1128/AAC.47.11.3548-3553.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.

Relevance of Soft-Tissue Penetration by Levofloxacin for Target Site Bacterial Killing in Patients with Sepsis

M. A. Zeitlinger,1 P. Dehghanyar,1 B. X. Mayer,1 B. S. Schenk,1 U. Neckel,1 G. Heinz,2 A. Georgopoulos,3 M. Müller,1 and C. Joukhadar1,2,4*

Department of Clinical Pharmacology, Division of Clinical Pharmacokinetics,1 Department of Internal Medicine II, Cardiac Intensive Care Unit,2 Department of Internal Medicine I, Division of Infectious Diseases and Chemotherapy,3 Institute of Pharmacology, University of Vienna Medical School, Vienna, Austria4

Received 26 February 2003/ Returned for modification 29 May 2003/ Accepted 20 August 2003

Antimicrobial therapy of soft tissue infections in patients with sepsis sometimes lacks efficiency, despite the documented susceptibility of the causative pathogen to the administered antibiotic. In this context, impaired equilibration between the antibiotic concentrations in plasma and those in tissues in critically ill patients has been discussed. To characterize the impact of tissue penetration of anti-infective agents on antimicrobial killing, we used microdialysis to measure the concentration-versus-time profiles of levofloxacin in the interstitial space fluid of skeletal muscle in patients with sepsis. Subsequently, we applied an established dynamic in vivo pharmacokinetic-in vitro pharmacodynamic approach to simulate bacterial killing at the site of infection. The population mean areas under the concentration-time curves (AUCs) for levofloxacin showed that levofloxacin excellently penetrates soft tissues, as indicated by the ratio of the AUC from time zero to 8 h (AUC0-8) for muscle tissue (AUC0-8 muscle) to the AUC0-8 for free drug in plasma (AUC0-8 plasma free) (AUC0-8 muscle/AUC0-8 plasma free ratio) of 0.85. The individual values of tissue penetration and maximum concentration (Cmax) in muscle tissue were highly variable. No difference in bacterial killing of a select Staphylococcus aureus strain for which the MIC was 0.5 µg/ml was found between individuals after exposure to dynamically changing concentrations of levofloxacin in plasma and tissue in vitro. In contrast, the decrease in the bacterial counts of Pseudomonas aeruginosa (MIC = 2 µg/ml) varied extensively when the bacteria were exposed to levofloxacin at the concentrations determined from the individual concentration-versus-time profiles obtained in skeletal muscle. The extent of bacterial killing could be predicted by calculating individual Cmax/MIC and AUC0-8 muscle/AUC0-8 plasma free ratios (R = 0.96 and 0.93, respectively). We have therefore shown in the present study that individual differences in the tissue penetration of levofloxacin may markedly affect target site killing of bacteria for which MICs are close to 2 µg/ml.

* Corresponding author. Mailing address: Department of Clinical Pharmacology, Division of Clinical Pharmacokinetics, Vienna University School of Medicine, Allgemeines Krankenhaus Waehringer Guertel 18-20, A-1090 Vienna, Austria. Phone: 43-1-40400-2981. Fax: 43-1-40400-2998. E-mail: christian.joukhadar{at}univie.ac.at.

Antimicrobial Agents and Chemotherapy, November 2003, p. 3548-3553, Vol. 47, No. 11
0066-4804/03/$08.00+0     DOI: 10.1128/AAC.47.11.3548-3553.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Marchand, S., Frasca, D., Dahyot-Fizelier, C., Breheret, C., Mimoz, O., Couet, W. (2008). Lung Microdialysis Study of Levofloxacin in Rats following Intravenous Infusion at Steady State. Antimicrob. Agents Chemother. 52: 3074-3077 [Abstract] [Full Text]  
  • Hutschala, D., Skhirtladze, K., Zuckermann, A., Wisser, W., Jaksch, P., Mayer-Helm, B. X., Burgmann, H., Wolner, E., Muller, M., Tschernko, E. M. (2005). In Vivo Measurement of Levofloxacin Penetration into Lung Tissue after Cardiac Surgery. Antimicrob. Agents Chemother. 49: 5107-5111 [Abstract] [Full Text]  
  • Zeitlinger, M. A., Erovic, B. M., Sauermann, R., Georgopoulos, A., Muller, M., Joukhadar, C. (2005). Plasma concentrations might lead to overestimation of target site activity of piperacillin in patients with sepsis. J Antimicrob Chemother 56: 703-708 [Abstract] [Full Text]  
  • Dehghanyar, P., Burger, C., Zeitlinger, M., Islinger, F., Kovar, F., Muller, M., Kloft, C., Joukhadar, C. (2005). Penetration of Linezolid into Soft Tissues of Healthy Volunteers after Single and Multiple Doses. Antimicrob. Agents Chemother. 49: 2367-2371 [Abstract] [Full Text]  
  • Cook, A. M. (2005). Pharmacokinetic Alterations of Antimicrobials in the Critically Ill. Journal of Pharmacy Practice 18: 75-83 [Abstract]  
  • Karjagin, J., Pahkla, R., Karki, T., Starkopf, J. (2005). Distribution of metronidazole in muscle tissue of patients with septic shock and its efficacy against Bacteroides fragilis in vitro. J Antimicrob Chemother 55: 341-346 [Abstract] [Full Text]  
  • Sauermann, R., Delle-Karth, G., Marsik, C., Steiner, I., Zeitlinger, M., Mayer-Helm, B. X., Georgopoulos, A., Muller, M., Joukhadar, C. (2005). Pharmacokinetics and Pharmacodynamics of Cefpirome in Subcutaneous Adipose Tissue of Septic Patients. Antimicrob. Agents Chemother. 49: 650-655 [Abstract] [Full Text]  
  • Steiner, I. M., Langenberger, H., Marsik, C., Mayer, B. X., Fischer, M., Georgopoulos, A., Muller, M., Heinz, G., Joukhadar, C. (2004). Effect of norepinephrine on cefpirome tissue concentrations in healthy subjects. J Antimicrob Chemother 53: 506-511 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»